Tacalyx raises €7.0M Seed round

The funding will be used to advance the company's discovery platform, progress obtained leads toward candidate selection, and start pre-clinical development of anti-TACA cancer therapies.

Source: https://www.prnewswire.com/news-releases/tacalyx-raises-7-million-in-seed-funding-to-generate-first-in-class-anti-taca-antibodies-for-cancer-treatment-300924902.html